Company: G
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001140361-25-013031
Chunk: 78

Company: Genpact LTD
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 78
---
ii) PSUs granted in 2023 and 2024, calculated based on target performance, and (iii) RSUs granted in 2023 and 2024, with respect to the number of shares that would have vested on the next vesting date. |

| (5) | Amount represents the estimated value of accelerated vesting of all outstanding and unvested equity awards granted to Mr. Kalra. |

| (6) | For each of these NEOs, this amount represents the estimated value of providing the NEO and the NEO’s dependents with health benefits for the period defined in such NEO’s employment agreement following the date of termination at the same level of coverage provided to our senior executives based in the same jurisdiction. The amounts are calculated based on the present value of the maximum liability with respect to each NEO and such NEO’s dependents under our applicable benefit plan in effect as of December 31, 2024. |

| (7) | Amount represents (i) for Mr. Weiner, the sum of 12 months of his base salary and his pro-rated target bonus for 2024, and (ii) for Ms. Vashisht and Messrs. Nanduru and Mehta, the sum of (a) six months of such NEO’s base salary, (b) one additional week of salary for each year of employment with the Company (up to a maximum of 12 additional weeks) and (c) such NEO’s pro-rated target bonus for 2024. |

| (8) | Amount represents the estimated value of accelerated vesting of the portion of all outstanding unvested (i) PSUs, (ii) RSUs and (iii) Company options, in each case that would have vested within 12 months after the termination date of December 31, 2024 had the NEO continued in service with the Company through such date. |

| (9) | Amount represents the estimated value of accelerated vesting of all outstanding and unvested equity awards granted to the NEO. |

| (10) | This amount was converted from Indian rupees at the rate of INR 1/US$0.0120. |

| (11) | None of our NEOs that remain employed by the Company currently qualify for retirement treatment under the terms of our equity award agreements. Mr. Tyagarajan stepped down as our President and Chief Executive Officer, effective as of February 9, 2024. Mr. Tyagarajan did not receive any severance